Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

NCT05946538 is registered in ClinicalTrials.gov with AusDiagnostics Pty Ltd. as lead sponsor.

NCT NCT05946538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05946538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics
Lead sponsor
AusDiagnostics Pty Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2023
Completion date
February 29, 2024
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory viral infection